WallStSmart

Chimera Investment Corporation (CIM)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 5701% more annual revenue ($12.76B vs $220.03M). WELL leads profitability with a 12.1% profit margin vs 0.6%. CIM appears more attractively valued with a PEG of 3.33. WELL earns a higher WallStSmart Score of 57/100 (C).

CIM

Hold

46

out of 100

Grade: D+

Growth: 4.3Profit: 5.5Value: 5.7Quality: 5.0
Piotroski: 4/9Altman Z: -0.27

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CIMUndervalued (+65.1%)

Margin of Safety

+65.1%

Fair Value

$37.46

Current Price

$11.13

$26.33 discount

UndervaluedFair: $37.46Overvalued
WELLSignificantly Overvalued (-87.0%)

Margin of Safety

-87.0%

Fair Value

$125.97

Current Price

$235.62

$109.65 premium

UndervaluedFair: $125.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CIM2 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Operating MarginProfitability
33.8%10/10

Strong operational efficiency at 33.8%

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

CIM4 concerns · Avg: 2.8/10
Market CapQuality
$935.16M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.1%3/10

ROE of 0.1% — below average capital efficiency

Profit MarginProfitability
0.6%3/10

0.6% margin — thin

PEG RatioValuation
3.332/10

Expensive relative to growth rate

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CIM

The strongest argument for CIM centers on Price/Book, Operating Margin.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : CIM

The primary concerns for CIM are Market Cap, Return on Equity, Profit Margin. Debt-to-equity of 5.57 is elevated, increasing financial risk. Thin 0.6% margins leave little buffer for downturns.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

CIM profiles as a value stock while WELL is a growth play — different risk/reward profiles.

CIM carries more volatility with a beta of 1.75 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 46/100) and 39.1% revenue growth. CIM offers better value entry with a 65.1% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chimera Investment Corporation

REAL ESTATE · REIT - MORTGAGE · USA

Chimera Investment Corporation is a real estate investment trust (REIT) in the United States. The company is headquartered in New York, New York.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?